Retraction of: Scientific Reports https://doi.org/10.1038/s41598-018-26496-0, published online 25 May 2018
The Editors have retracted this Article. After the publication of this Article it was brought to the Editors' attention that some of the data appear to overlap with data in other articles with different authors, where they are attributed to different experiments. Specifically:
-
In Figure 2A images of scratch wound assays in BxPC-3 and Panc-1 cells in control and I-BET762 groups appear to overlap with data described in1,2.
-
In Figure 2D images of colony formation assays in BxPC-3 and Panc-1 cells in control and I-BET762 groups appear to overlap with data described in3,4,5,6.
-
In Figure 3A the images of sphere formation assays appear to overlap with those described in7.
The Editors reached out to the Authors to request raw data. The Authors were unable to provide the data and the concerns remain unresolved. The Editors therefore no longer have confidence in the results presented in this Article. All Authors agree to this retraction.
References
Wang, Z. et al. CtBP1 promotes tumour-associated macrophage infiltration and progression in non-small-cell lung cancer. J. Cell Mol. Med. 24(19), 11445–11456. https://doi.org/10.1111/jcmm.15751 (2020).
Han, S., Zhen, W., Guo, T., Zou, J. & Li, F. RETRACTED ARTICLE: SETDB1 promotes glioblastoma growth via CSF-1-dependent macrophage recruitment by activating the AKT/mTOR signaling pathway. J. Exp. Clin. Cancer Res. 39, 218. https://doi.org/10.1186/s13046-020-01730-8 (2020).
Zhang, Y. et al. Increased Six1 expression in macrophages promotes hepatocellular carcinoma growth and invasion by regulating MMP-9. J. Cell Mol. Med. 23(7), 4523–4533. https://doi.org/10.1111/jcmm.14342 (2019).
Dai, Y., Huang, J., Xiang, B., Zhu, H. & He, C. Antiproliferative and apoptosis triggering potential of paclitaxel-based targeted-lipid nanoparticles with enhanced cellular internalization by transferrin receptors—A study in leukemia cells. Nanoscale Res. Lett. 13, 271. https://doi.org/10.1186/s11671-018-2688-x (2018).
Lee, Y. J. et al. Cytotoxic compounds from juglans sinensis dode display anti-proliferative activity by inducing apoptosis in human cancer cells. Molecules 21(1), E120. https://doi.org/10.3390/molecules21010120 (2016).
Ji, L. et al. Actein induces autophagy and apoptosis in human bladder cancer by potentiating ROS/JNK and inhibiting AKT pathways. Oncotarget 8(68), 112498–112515. https://doi.org/10.18632/oncotarget.22274 (2017).
Alberti, L., Losi, L., Leyvraz, S. & Benhattar, J. Different effects of BORIS/CTCFL on stemness gene expression, sphere formation and cell survival in epithelial cancer stem cells. PLoS ONE 10(7), e0132977. https://doi.org/10.1371/journal.pone.0132977 (2015).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Xie, F., Huang, M., Lin, X. et al. Retraction Note: The BET inhibitor I-BET762 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic effect of gemcitabine. Sci Rep 13, 20934 (2023). https://doi.org/10.1038/s41598-023-48298-9
Published:
DOI: https://doi.org/10.1038/s41598-023-48298-9
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
